Soy protein in early diabetic nephropathy
Diabetic Nephropathy · Diabetes Mellitus
Enrolment not recorded · Results not recorded
Nutraceutical · Defined rodent purified diet; no ChEMBL entity. No trial tests the AIN-76A formulation itself; evidence recorded is protein-source-level (isolated soy protein, casein fraction) in human dietary studies.
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Diabetic Nephropathy · Diabetes Mellitus
Enrolment not recorded · Results not recorded
Cardiovascular Disease
Enrolment: 20 · Results not recorded
Gastrointestinal Disease
Enrolment: 24 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Leg-out partial-body irradiation with 320 kV x-rays at 11 Gy midline for radiation nephropathy, and whole-thorax irradiation at 12.75 Gy mid-lung for radiation pneumonitis
Switching to the AIN-76A diet after irradiation markedly reduced radiation nephropathy and non-significantly reduced pneumonitis morbidity, whereas switching before irradiation had no effect and the protein source did not matter.
Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.